期刊文献+

端粒酶活性抑制研究进展

The Progress of Research about Inhibition of Telomerase Activity
在线阅读 下载PDF
导出
摘要 端粒酶是一种核糖蛋白,包括端粒酶RNA、端粒酶相关蛋白和端粒酶催化亚基三个主要组成部分,端粒和端粒酶具有特殊结构和功能,是近年来分子生物学研究的热点。端粒酶在85%~95%的恶性肿瘤中呈阳性,而正常体细胞则呈阴性,因此是一类潜在的高选择性的抗肿瘤药物,抑制剂的开发研究为恶性肿瘤的早期诊断,预后估计和基因治疗开辟了新的道路。 telomerase is a nucleoglucoprotein which include telomerase RNA,telomerase associated protein and telomerase catalytic subunit, three main ingredient, telomere and telomerase which have special structure and function, are the hot spot of molecular biology research lately. Telomerase is masculine in 85% - 95% malignant tumor, but negative in normal body cell, so is a potential high-selective anti-tumor drug, development and research oftelomerase inhibitor pave a new way for early diagnosis of malignant tumor, prognosis estimation and gene therapy.
机构地区 沈阳农业大学
出处 《吉林畜牧兽医》 2006年第7期15-18,共4页 Jilin Animal Husbandry and Veterinary Medicine
关键词 端粒 端粒酶 端粒酶抑制剂 肿瘤 telomere, telomerase, telomerase inhibitor, tumor.
  • 相关文献

参考文献21

  • 1吕盈盈,袁孟彪,靳大川,高艳景.针对端粒酶的HDV核酶的设计及其对端粒酶活性抑制研究[J].临床肝胆病杂志,2003,19(5):281-282. 被引量:3
  • 2张红梅,张丽珊.端粒酶活性抑制的研究进展[J].国外医学(遗传学分册),2000,23(3):130-133. 被引量:5
  • 3龚太平,车玫,王伟平,袁新初.端粒酶活性抑制与肿瘤研究进展[J].湖北民族学院学报(医学版),2002,19(1):42-45. 被引量:2
  • 4Duncan VE et al.Anticancer Res. 1998,18(6A):4105-4108.
  • 5Nielsen PE et al.Science. 1991,254:1497-1500.
  • 6Horikawa l.Oshimura M. and Barret J C.Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence[J]. Mol Carcinog,1998,22(2):65-72.
  • 7Husatomi H, Nagao K, Kanamaru T. Levels oftelomerase catalytic subunit mRNA as a predictor of potential malignancy [J]. Int J Oncol, 1999,14(4):727-730
  • 8Meyerson M et al.Cell, 1997.90(4):785-795.
  • 9Zahler AM et al. Nature. 1991,350:718-720.
  • 10Izbicka E et al. Cancer Res. 1999,59(3):639-644.

二级参考文献74

  • 1陈仕明,赵成龙,吴翚,高广忠,范慕贞.人早幼粒白血病细胞移植瘤株的建立及其实验治疗[J].中日友好医院学报,1992,6(2):68-71. 被引量:3
  • 2徐淑云.药理实验方法学(第2版)[M].北京:人民卫生出版社,1991.180-191.
  • 3Nam WK,Piatyszek MA,Prowse KR,et al.Specific association of human telomerase activity with immortal cells and cancer[J].Science,1994,266:2011-15
  • 4Folini H, Collda G, Villa R, et al. Inhibition of telometrase activity by a hammerhead ribegyam targeting the RNA component of telometrase in human melanoma cells[J]. J Invest Dermatol, 2000, 114(2) :259 - 61.
  • 5Fauzi H, Kawakami J, Nishikawa F, et al. Analysis of the cleavage reaction of a traps - acting human hepatitis delta virus ribozyme[J]. Nucleic Acid Res, 1997,(25):3124-30.
  • 6Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase[J]. Science, 1995, 269:1236-41.
  • 7Autexier C, Pruzan R, Funk WD, et al. Reconstitution of human telomerase activity and indentification of minimal functional region human telomerase RNA[J].EMBOJ, 1996, 15(21):5928-44.
  • 8Nishikawa F, RoyM, Fauzi H,et al. Detailed analysis stem Ⅰ and its 5' and 3' neighbor regions in the trans-acting HDV ribozyme[J].Nucleic Acids Res, 1999, 27(2) :403 -41.
  • 9Matysiak M, Wizesinski J, Ciesiolka J. Sequential folding of genomic ribozyme of the hepatitis delta virus: struetnd analysis of RNA transcription intermediates[J]. J Mol Biol, 1999, 291(2):283-94.
  • 10Fauzi H, Kawakami J, Nishikawa F, et al. Analysis of the cleavage reaction of a trans - acting human hepatitis delta vires ribegyme[J]. Nucleic Acids Res, 1997, 25(15):3124-30.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部